Prot# CA180267: An Open-Label Trial to Evaluate the Safety of Dasatinib in the Treatment of Scleroderma Pulmonary Interstitial Fibrosis

Project: Research project

Project Details

StatusFinished
Effective start/end date1/22/091/22/12

Funding

  • Bristol-Myers Squibb Company (CA180267)